The latest immunotherapy news and developments
Cancer drug resistance study raises immune red flags
Sooner or later, most cancer patients develop resistance to the very chemotherapy drugs designed to…
Browsing: Immunotherapy
Study reveals how ‘hypermutated’ malignant brain tumours escape chemotherapy and immunotherapy
Cancers whose cells are riddled with large numbers of DNA mutations often respond favourably to…
Tailoring treatment for triple-negative breast cancer
Immunotherapies have revolutionised treatment for people with a variety of cancers. But when given to…
Immunotherapy treatment after chemotherapy significantly slows metastatic bladder cancer
Using immunotherapy immediately after chemotherapy treatment in patients with metastatic bladder cancer significantly slowed the…
Cancer scientists aim to use protein power to stop tumour growth
In 2018, approximately 324,000 men died from cancer in the United States. The combination of…
Immunotherapy prior to surgery is effective in colon cancer
Patients with colon cancer, but no distant metastases yet, can benefit from a short course…
Immunotherapy effective in metastatic prostate cancers with specific markers of immune activation
Although metastatic castration-resistant prostate cancer (mCRPC) typically has limited response to immunotherapy, a subset of…
Majority of patients responded in CAR T-cell trial for mantle cell lymphoma
Study showed 93% of patients responded with 67% achieving complete response A one-year follow-up study…
CAR T-cell therapy for solid tumours may advance cancer treatments
Immunotherapy with genetically modified lymphocytes, such as CAR-T cells, is one of the most promising…
Combination creates powerful central memory T cells for cellular therapy
Interleukin-21 plus panobinostat re-program effector cells to a more persistent type of T cell Treating…